Correction to: Advances in gene and cellular therapeutic approaches for Huntington’s disease
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1- —National Key R&D Program of China10.13039/501100012166
- —National Natural Science Foundation of China10.13039/501100001809
- —CAMS Innovation Fund for Medical Sciences
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenetic Neurodegenerative Diseases
This is a correction to: Xuejiao Piao, Dan Li, Hui Liu, Qing Guo, Yang Yu, Advances in gene and cellular therapeutic approaches for Huntington’s disease, Protein & Cell, 2024; https://doi.org/10.1093/procel/pwae042
In the version originally published, in Figure 3 the key indicating symbols for target RNA and target DNA was reversed. This error has been corrected in Figure 3 within article.